Regulatory Challenges and Opportunities for Gene Therapy
Time: 2:00 pm
day: Track B afternoon
- What safety data are the regulators looking for from preclinical data to proceed
into a clinical trial?
- Key regulatory interactions with the FDA early on in development
- Case study: IND filing of a second-generation gene therapy for Hemophilia A